Your Unread Messages in PsychiatrySee All >> Messages include industry-sponsored communications and special communications from MDLinx
MDLinx Conference Center
Fall Medical Conferences are right around the corner. Check out the must attend meetings.
Smartest Doc Challenge
1000s of Clinical Pearls available now for your self-assessment in the Smartest Doc Physician Reviews
Stay Connected with MDLinx
Smartest Doc Board Exam Prep
Take advantage of 50 new and challenging questions just added to the Psychiatry Board Exam Prep Course. Prep Now!
There are 5,870 job openings in Psychiatry. Find your next job.
Top Medical News
Stay current with the latest medical news making headlines from this week
1 The ‘disconnect’ between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications Acta Psychiatrica Scandinavica, May 1, 2015 Evidence Based Medicine
2 Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study Journal of Psychiatric Research, May 12, 2015
3 Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial Journal of Psychopharmacology, May 13, 2015
4 Anti-depressant therapy and cancer risk: A nested case-control study European Neuropsychopharmacology, May 8, 2015
5 Cause of regression in individuals with Down syndrome identified University of Missouri News, May 14, 2015
6 Relationship between thyroid-stimulating hormone levels and risk of depression among the general population with normal free T4 levels Psychoneuroendocrinology, May 7, 2015
7 Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior Pediatric Research, May 26, 2015
8 Could brain scans help predict schizophrenia? Cardiff University News, May 12, 2015
9 Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study Psychoneuroendocrinology, May 13, 2015
10 Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods BMC Psychiatry, May 6, 2015 Free full text
© 2015 M3 USA Corporation. ALL Rights Reserved.